These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29432709)

  • 1. Neprilysin inhibition and endothelin-1 elevation: Focus on the kidney.
    Roksnoer LCW; Uijl E; de Vries R; Garrelds IM; Jan Danser AH
    Eur J Pharmacol; 2018 Apr; 824():128-132. PubMed ID: 29432709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
    Roksnoer LC; van Veghel R; de Vries R; Garrelds IM; Bhaggoe UM; Friesema EC; Leijten FP; Poglitsch M; Domenig O; Clahsen-van Groningen MC; Hoorn EJ; Jan Danser AH; Batenburg WW
    Kidney Int; 2015 Jul; 88(1):109-20. PubMed ID: 25830765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure.
    Dizaye K; Ali RH
    BMC Pharmacol Toxicol; 2019 May; 20(1):23. PubMed ID: 31053170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.
    Park KS; Li Y; Zhang Y; Gerbes AL; Liu H; Swain MG; Lee SS
    Br J Pharmacol; 2003 May; 139(1):81-8. PubMed ID: 12746226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.
    Clements RT; Vang A; Fernandez-Nicolas A; Kue NR; Mancini TJ; Morrison AR; Mallem K; McCullough DJ; Choudhary G
    Circ Heart Fail; 2019 Nov; 12(11):e005819. PubMed ID: 31707802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
    Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
    Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
    Nougué H; Pezel T; Picard F; Sadoune M; Arrigo M; Beauvais F; Launay JM; Cohen-Solal A; Vodovar N; Logeart D
    Eur J Heart Fail; 2019 May; 21(5):598-605. PubMed ID: 30520545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene.
    Stasch JP; Hirth-Dietrich C; Ganten D; Wegner M
    Am J Hypertens; 1996 Aug; 9(8):795-802. PubMed ID: 8862226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.
    Ibrahim NE; McCarthy CP; Shrestha S; Gaggin HK; Mukai R; Szymonifka J; Apple FS; Burnett JC; Iyer S; Januzzi JL
    J Am Coll Cardiol; 2019 Mar; 73(11):1273-1284. PubMed ID: 30898202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure.
    Trivedi RK; Polhemus DJ; Li Z; Yoo D; Koiwaya H; Scarborough A; Goodchild TT; Lefer DJ
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29502102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neprilysin with sacubitril without RAS blockage aggravates renal disease in Dahl SS rats.
    Polina I; Spicer MJ; Domondon M; Schibalski RS; Sarsenova E; Sultanova RF; Ilatovskaya DV
    Ren Fail; 2021 Dec; 43(1):315-324. PubMed ID: 33541194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.
    Trapani AJ; Smits GJ; McGraw DE; Spear KL; Koepke JP; Olins GM; Blaine EH
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):419-24. PubMed ID: 2476621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury.
    Uijl E; 't Hart DC; Roksnoer LCW; Groningen MCC; van Veghel R; Garrelds IM; de Vries R; van der Vlag J; Zietse R; Nijenhuis T; Joles JA; Hoorn EJ; Danser AHJ
    J Hypertens; 2020 Apr; 38(4):755-764. PubMed ID: 31790054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan.
    Chrysant SG
    J Am Soc Hypertens; 2017 Jul; 11(7):461-468. PubMed ID: 28652105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.
    Habibi J; Aroor AR; Das NA; Manrique-Acevedo CM; Johnson MS; Hayden MR; Nistala R; Wiedmeyer C; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2019 Mar; 18(1):40. PubMed ID: 30909895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.
    Olins GM; Krieter PA; Trapani AJ; Spear KL; Bovy PR
    Mol Cell Endocrinol; 1989 Feb; 61(2):201-8. PubMed ID: 2521834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.
    Malek V; Sharma N; Sankrityayan H; Gaikwad AB
    Life Sci; 2019 Mar; 221():159-167. PubMed ID: 30769114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.